How it works
Source & clear — end to end
A company applies or is invited. We run Precision Diligence and team review before syndication opens.
- Step 1
Source & clear
A company applies or is invited. We run Precision Diligence and team review before syndication opens.
- Step 2
One SPV per deal
BioSyndex forms and manages a dedicated Delaware SPV for each approved opportunity. Companies receive one wire and one cap table entry. Investors get simplified reporting and K-1s.
- Step 3
Invite & commit
Verified accredited investors subscribe to that deal's SPV through our FINRA-registered broker-dealer partner—not as direct shareholders in the company.
- Step 4
Close
When the SPV reaches its target, funds wire to the company in one transfer—a single cap table line for the issuer.
- Step 5
Report
Company updates, distributions, and tax reporting (e.g. K-1s) flow to SPV members on a pro-rata basis.
Founding issuers — first deal lists free
Founding issuers list their first private placement free. Verified accredited investors participate free, always.